Development and Validation of HPLC-UV Method for the Determination of Favipiravir in Human Plasma
Introduction. Coronavirus disease (COVID-19) is an acute infectious disease caused by SARS-CoV-2 (severe acute respiratory syndrome-related coronavirus 2). Favipiravir is a synthetic prodrug with antiviral activity used for the treatment of COVID-19. There are oral and parenteral dosage forms of fav...
| Principais autores: | , , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Russian |
| Publicado em: |
LLC Center of Pharmaceutical Analytics (LLC «CPHA»)
2022-09-01
|
| coleção: | Разработка и регистрация лекарственных средств |
| Assuntos: | |
| Acesso em linha: | https://www.pharmjournal.ru/jour/article/view/1304 |